Fraxiparine 3075IU Injection
By Fraxiparine
Rx
0ml Injection in a Vial

Composition
Nadroparin(3075IU)

Manufacturer - Glaxo SmithKline Pharmaceuticals Ltd
Dr. Annie Besant Road, Mumbai - 400 030

Expires on or after
December, 2025

liver
Limited information is currently available regarding the use of Fraxiparine 3075IU Injection in patients with liver disease. It is important to consult with your doctor before using this medication to ensure it is safe and appropriate for your specific situation. Your doctor will be able to provide guidance on the potential risks and benefits of using Fraxiparine 3075IU Injection if you have liver issues. It is crucial to follow your doctor's advice closely to minimize any potential adverse effects on your liver health.

kidney
Fraxiparine 3075IU Injection should be used carefully in patients with severe kidney disease. Adjusting the dose may be necessary. Consult your doctor for proper guidance.

alcohol
Consult your doctor when consuming alcohol with Fraxiparine 3075IU Injection.

driving
It is not clear if Fraxiparine 3075IU Injection affects driving ability. Avoid driving if symptoms impact focus and reaction time.

pregnancy
Fraxiparine 3075IU Injection could be unsafe during pregnancy. Limited human studies and animal research indicate potential harm to the baby. Your doctor will assess benefits versus risks before recommending this medication. Consult your doctor.

breastfeeding
Fraxiparine 3075IU Injection may not be safe during breastfeeding as it might pass into breastmilk and harm the baby. Consult your doctor before use.
Habit Forming | No |
Chemical Class | Low molecular weight heparin (LMWH) |
Therapeutic Class | BLOOD RELATED |
Action Class | Low molecular weight Heparin (LMWH) |
₹287.47
₹319.41
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025